HomeCompareFOCKX vs JNJ

FOCKX vs JNJ: Dividend Comparison 2026

FOCKX yields 7.85% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FOCKX wins by $13.6K in total portfolio value
10 years
FOCKX
FOCKX
● Live price
7.85%
Share price
$24.06
Annual div
$1.89
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.6K
Annual income
$1,289.71
Full FOCKX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FOCKX vs JNJ

📍 FOCKX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFOCKXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FOCKX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FOCKX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FOCKX
Annual income on $10K today (after 15% tax)
$667.00/yr
After 10yr DRIP, annual income (after tax)
$1,096.25/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, FOCKX beats the other by $392.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FOCKX + JNJ for your $10,000?

FOCKX: 50%JNJ: 50%
100% JNJ50/50100% FOCKX
Portfolio after 10yr
$26.8K
Annual income
$1,058.75/yr
Blended yield
3.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FOCKX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FOCKX buys
0
JNJ buys
0
No recent congressional trades found for FOCKX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFOCKXJNJ
Forward yield7.85%3.36%
Annual dividend / share$1.89$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$33.6K$20.0K
Annual income after 10y$1,289.71$827.78
Total dividends collected$10.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FOCKX vs JNJ ($10,000, DRIP)

YearFOCKX PortfolioFOCKX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,485$784.70$10,676$355.77+$809.00FOCKX
2$13,131$842.25$11,407$389.39+$1.7KFOCKX
3$14,950$899.98$12,198$426.53+$2.8KFOCKX
4$16,954$957.63$13,056$467.62+$3.9KFOCKX
5$19,156$1,014.96$13,987$513.12+$5.2KFOCKX
6$21,569$1,071.74$14,998$563.56+$6.6KFOCKX
7$24,206$1,127.78$16,098$619.52+$8.1KFOCKX
8$27,083$1,182.89$17,295$681.69+$9.8KFOCKX
9$30,216$1,236.92$18,599$750.82+$11.6KFOCKX
10$33,621$1,289.71$20,022$827.78+$13.6KFOCKX

FOCKX vs JNJ: Complete Analysis 2026

FOCKXStock

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities principally traded on NASDAQ® or an over-the-counter (OTC) market, which has more small and medium-sized companies than other markets. The fund invests more than 25% of total assets in the technology sector. It invests in domestic and foreign issuers. The fund invests in either growth stocks or value stocks or both. It is non-diversified.

Full FOCKX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FOCKX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FOCKX vs SCHDFOCKX vs JEPIFOCKX vs OFOCKX vs KOFOCKX vs MAINFOCKX vs ABBVFOCKX vs MRKFOCKX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.